Skip to content

Rallis India Limited (RALLIS)

Micro Cap

Chemicals stocks · Micro cap · NSE

Rallis India Limited empowers farmers with innovative solutions from seed to harvest. Its portfolio includes crop protection (herbicides, insecticides, fungicides), soil & plant health (organic/bio-fertilizers), and seeds (Rice, Bajra, Maize, Cotton & Mustard). The company operates B2C, B2B, and Custom Synthesis Manufacturing segments.

₹204.65
-0.28 · -0.14%
Market cap ₹3,991 Cr
Data qualityFresh enough for analysisQuote updated 19 Oct, 03:31 pm IST
Details
Quote19 Oct, 03:31 pm IST
Base fundamentals14 Oct 2026 · screener
Latest result21 Jul, 01:36 am IST
Score20 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags15 Aug 2026
Coverage14/14 · 100%
Valuation2026-07-20 · Rf 6.8% · Chemicals P/E 33.1 (n=45)
Technical timing lens

Trend score and candlestick chart

42Neutral

SMA20 -3.2% / mo · MACD + · near 52W low · sector -4.2pp vs Nifty 500 (3M)

Stock trend: 40
Sector RS: 46
Sector 3M: -9.8% vs Nifty 500 -5.6%

Latest mapped FPI equity flow was not positive. View sector evidence

Technical chart

RALLISD candles · FIT view-20.2%
Latest close ₹204.65 on 2026-10-19
Bar
-0.2%
RSI
55
MACD hist
1.10
52W pos
11%
Visible chart range
Candle interval
2026-10-19O ₹205.02H ₹205.99L ₹203.17C ₹204.65Vol 3.9L sh
₹188.92₹213.56₹238.20₹262.84₹287.4852L₹204.652026-032026-06VolRSIMACD2026-042026-062026-082026-092026-11
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context

Relative performance and chart statistics

Adjusted completed-session prices, rebased to 100

RALLISNifty ChemicalsNifty 500
-20%-12%-4%+4%20 Jul1 Sept19 Oct19 Oct 2026RALLIS -14.7%Nifty Chemicals -8.5%Nifty 500 -5.6%
RALLIS
-14.7%
Nifty 500
-5.6%
Nifty Chemicals
-8.5%
Vs Nifty 500
-9.1 pp
Chart stats
19 Oct 2026
From 52W high
-33.0%
₹305.6
52W range position
10%
₹193.4 - ₹305.6
ATR (14)
2.2%
₹4.6
Volume vs 20D
0.93x
Latest completed session
Avg traded value
₹8.2 Cr
20-session average
20D price channel
₹193.4 - ₹206.9
16.2% annualized volatility
Research snapshot

What the evidence says now

Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is mixed.

Suggested next step
Research, do not rush
The evidence is not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
Legacy · WATCHLIST
38

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Latest result
Good
70

Revenue +6.8% · PAT +31.6% YoY

Technical
Neutral
42

Price trend and sector-relative-strength timing.

Valuation
Legacy model
-194.6%

Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.

Trust
Limited evidence
75

Financial-only signal; management claim evidence is not sufficient yet.

Financials

Fundamentals, quarterly history, margins, returns and balance-sheet evidence

Latest result

Quarter ended 30 Jun 2026

Good · 70/100

Rev +7% YoY · PAT +32% YoY · margin expansion · +124% QoQ · operating leverage

Filed 20 Jul 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹1,022 Cr+6.8%+124.1%
EBITDA₹185 Cr+23.3%+18600.0%
Operating margin18.0%+200 bps+1820 bps
PAT₹125 Cr+31.6%NDF
PAT margin12.2%+230 bps+1552 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Fundamentals

Valuation

P/E
17.50
P/B
1.95
EV/EBITDA
7.88
Market Cap
3991.00Cr

Profitability

ROE
10.20%
ROCE
14.10%
ROA
6.40%
Dividend Y
1.46%

Growth (CAGR)

Revenue 5Y
4.00%
EPS 5Y
-2.00%
Revenue 3Y
-1.00%
EPS 3Y
30.00%

Balance Sheet

Debt/Equity
0.03
Interest Coverage
49.50×
Altman Z
3.93
Book Value
105.00

Cash Flow

FCF Yield
1.93%
FCF Positive Y
12/5
OCF
172.00 Cr
EPS TTM
11.01

Shareholding

Promoter Hold
55.08%
Promoter Pledge
0.00%
Momentum 52W
11%

Financial History

Updated 20/10/2026

Revenue

₹ Cr
Latest: 1,022+124.1% vs prev
01022Sep 2023: 832Dec 2023: 598Mar 2024: 436Jun 2024: 783Sep 2024: 928Dec 2024: 522Mar 2025: 430Jun 2025: 957Sep 2025: 861Dec 2025: 623Mar 2026: 456Jun 2026: 1,022Q2 23Q3 23FY24Q1 24Q2 24Q3 24FY25Q1 25Q2 25Q3 25FY26Q1 26

Net Profit

₹ Cr
Latest: 125+933.3% vs prev
-32.00125.0Sep 2023: 82.0Dec 2023: 24.0Mar 2024: -21.0Jun 2024: 48.0Sep 2024: 98.0Dec 2024: 11.0Mar 2025: -32.0Jun 2025: 95.0Sep 2025: 102Dec 2025: 2.0Mar 2026: -15.0Jun 2026: 125Q2 23Q3 23FY24Q1 24Q2 24Q3 24FY25Q1 25Q2 25Q3 25FY26Q1 26
ROE is shown only in the Annual view — quarterly equity data isn't published.

Technicals

Trend interpretation, Stage 2, relative strength, volume and indicator evidence

Daily technical trend read

Mixed signals

Signals are conflicting — long-term trend down. RSI 55. Wait for confirmation.

  • Price below SMA200 (long-term downtrend) — short-term bounces likely countertrend.
  • SMA20 falling (~3.3% over last month) — short-term momentum negative.
  • RSI(14) at 55 — rising, no extreme reading.
  • MACD above signal, histogram expanding — bullish momentum building.
  • 31% off 52W high · 6% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Nifty 500 leadership

Relative Strength & Trend Stage

29
RS percentile
Stage 4 Downtrend
1M return
+0.4%
3M return
-14.7%
6M return
-23.1%
1Y return
-21.9%
RS 1D
+1
RS 20D
+14
Sector rank
#14
Industry rank
-
Stage evidence
  • Price is 10.5% below the 30-week proxy.
  • The 50-DMA is below the 30-week proxy and its slope is falling -3.2%.
  • Both 3-month and 6-month returns are negative.
50-DMA
price below
200-DMA
price below
Sector
weakening
Industry
unranked
Relative-strength line vs Nifty 500 (base 100)
262 observations
19 Oct 2026Value 68.41+0.90%
63738393103Sept 25Feb 26Jun 26Oct 2668
RS vs Nifty 50068

Valuation & peers

U-Score 38 · legacy U-Score band WATCHLIST · valuation evidence and comparable companies

38U-SCORE
WATCHLIST

Fundamental score breakdown

U band · WATCHLIST
Valuation7/30
Growth4/25
Quality4/20
Balance Sheet12/15
Cash Flow5/10
Piotroski
8/9 (+5)
Penalties
1
Raw sum
38

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

38/100 · legacy band WATCHLIST

Positive drivers

  • Piotroski is strong at 8/9.
  • Balance sheet contributes 12/15 to the score.
  • Cash flow contributes 5/10 to the score.

Main drags

  • Fair-value margin of safety is negative at -194.6%.
  • Growth is weaker at 4/25; verify the latest quarterly trend.
  • Quality is weaker at 4/20; verify the latest quarterly trend.
Sector valuation model

Cyclical valuation: normalized earnings, not just trailing PE

Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.

Cyclical normalized
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
17.5
PB
1.9
EV/EBITDA
7.9
ROE
10.2%
ROCE
14.1%
FCF Yield
1.9%
Debt/Equity
0.0
MoS
-194.6%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 20 Oct 2026
v4.3-runtime-valuation
Final score
38
Previous: 38
Legacy U-Score band
WATCHLIST
Previous: WATCHLIST
Margin of safety
-194.6%
Previous: -194.6%

Score history

12 stored score snapshots. Latest stored move: +0 points.

20 Oct 2026
v4.3-runtime-valuation
33
33
33
33
33
41
41
41
38
38
38
38

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
₹161.28
-26.9% MoS
Growth-justified P/E
6.3
Growth-justified Value
₹69.47
-194.6% MoS
PEG
—

Comparable companies

Peers

Business-comparable peers in Chemicals — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.

Compare all ↗
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
DHANUKA
Small
Dhanuka Agritech Limited
Agrochemicals
match 149
76
13.9
22.0%
+67%
DEEP VALUE
BHAGCHEM
Small
Bhagiradha Chemicals & Industries Limited
Agrochemicals
match 148
16
108.0
2.6%
-1678%
OVERVALUED
UPL
Mid
UPL Limited
Agrochemicals
match 148
32
22.6
5.6%
-478%
WATCHLIST
BAYERCROP
Large
Bayer Cropscience Limited
Agrochemicals
match 147
26
327.0
15.8%
-5483%
OVERVALUED
GSPCROP
Small
GSP Crop Science Limited
Agrochemicals
match 147
46
20.3
16.5%
+1%
FAIR VALUE

Business, management & trust

Growth engines, risks, management commitments and evidence-backed delivery

Business and thesis

Where growth can come from, and what can break the case

Thesis intactReviewed 2026-07-21T00:41:05.401Z
Management commentary snapshot

Rallis India reported a 7% YoY revenue growth to Rs. 1,022 Cr in Q1 FY27, driven by strong domestic formulation placement. EBITDA grew 23% YoY to Rs. 184 Cr, and PAT increased 31% YoY to Rs. 125 Cr, despite a tough operating environment.

The company delivered resilient Q1 FY27 results with strong EBITDA and PAT growth, primarily driven by domestic B2C crop protection. While B2B exports and CSM faced declines, new product launches and strategic focus on underserved segments and SPH indicate continued efforts to drive future growth despite market headwinds.

Growth engines

Domestic Formulation Growth

Topline growth of 7% driven by strong placement and campaign activities across key markets in domestic formulation.

B2C Business Expansion

Overcoming challenges, B2C business delivered 19% revenue growth.

New Product Launches

Launched 3 new products during 1QFY27 (2 Herbicides, 1 Insecticide) and 9 products across Cotton, Millet, and Paddy in Seeds business.

Soil & Plant Health Solutions

Soil & Plant Health business registered volume growth in select key products through pre-placement.

Tailwinds

Aggressive Pre-placement & Liquidation

Domestic formulations growth driven by aggressive preplacement, liquidation efforts, and drive for volume scale up.

Digital Marketing Interventions

Digital marketing interventions continue to promote products through Anubandh Edge Schemes, Farmers QR Code/ Reward Schemes, and Sampark+.

Headwinds

Subdued Overall Demand

Overall demand was subdued with driest June in last 12 years, delayed Kharif sowings, crop shifts and reduction in cotton acreages.

Geopolitical Impact

Industry impacted by war situation, leading to panic buying of commodities with significant price increases.

Trade Channel Cash Crunch

Trade channels rushed to secure fertilizer, resulting in cash crunch for Crop Protection causing conservative inventory stocking and slower liquidation.

Illegal HTBT Cotton Spread

Extensive spread of illegal HTBT cotton contributed to reduction in cotton acreages.

Risk radar

Monsoon Dependency

Delayed monsoon and Kharif sowings highlight reliance on weather patterns for agricultural demand.

Crop Shifts

Farmer crop switch and crop shift among other challenges indicate demand volatility.

International Market Volatility

War situation in West Asia impacted planning and led to significant price increases for commodities.

Management accountability

What management said, and what results must prove

Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.

Analyst reading lens
Compare YOY

Agriculture is a seasonal business, and Q1 results are best compared to the same quarter in the previous year to account for seasonal variations in demand, sowings, and market conditions.

Sector KPIs management disclosed

Revenue

Revenue increased by 7% from Rs. 957 Cr. in Q1FY26 to Rs. 1,022 Cr in Q1FY27.

EBITDA

EBITDA increased by 23% from Rs. 150 Cr. in Q1FY26 to Rs. 184 Cr. in Q1FY27.

PAT after Exceptional Items

PAT increased by 31% from Rs. 95 Cr. in Q1FY26 to Rs. 125 Cr. in Q1FY27.

Crop Protection B2C Revenue

Q1FY27 Crop Protection B2C revenue increased by 19% vs Q1FY26.

Management forward view

Strategic Focus

Management aims to widen reach, extend portfolio offerings, build strategic alliances, and focus on underserved crop protection segments.

Innovation & R&D

Mission includes accelerating innovation to market and targeting R&D investments.

Operational Excellence

Management is focused on driving operational excellence and cost competitiveness.

Digital & Customer Centricity

Leveraging digital, collaborations, and alliances, with a core value of customer centricity.

Thesis monitor

Numbers and claims to verify in the next filings

CheckpointCurrent evidenceWhat to verify next
Domestic B2C Growth19% revenue growth YoY in Q1FY27.Sustained double-digit growth and market share gains in domestic formulations.
New Product PipelineLaunched 3 new products in Crop Protection and 9 in Seeds in Q1FY27.Successful commercialization and revenue contribution from new launches.
B2B/CSM PerformanceB2B exports including CSM revenue declined by 16% YoY.Recovery in international demand and improved unit margins in B2B/CSM segments.
Monsoon & Sowing TrendsDelayed monsoon and Kharif sowings impacted Q1.Favorable monsoon progression and improved Kharif sowings for H2 FY27.

Verification checkpoints are IndiaPulse research interpretation, not investment advice.

Trust Score
75Limited evidence · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Limited evidence: Claim history is still being built. It ranks around the 78th percentile of the scored universe and 64th percentile within Chemicals. Main check: financial discipline is weak at 50/100.

This is a financial-behaviour screen, not a claim-tested management reliability verdict.

Computed 05 Sept 2026
management-trust-v1
120 docs text-extracted · 42 concalls text-extracted
Score band
Limited evidence

Financial behaviour is scored, but management claims do not yet have enough outcome checks.

Relative rank
78th percentile

overall median 67 · Chemicals: 64th pctile, median 73 · Micro: 60th pctile, median 73

Evidence depth
Financial-only

120 documents have extracted text, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Limited evidence · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Can support position sizing if valuation and trend also agree.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
86
strong · holding, pledge, alignment
Cash flow
77
strong · profit to cash conversion
Balance sheet
96
strong · leverage and solvency
Discipline
50
watch · capital discipline
Results
62
acceptable · quarterly consistency

Trust positives

  • ▸Promoter holding is 55.1%.
  • ▸Promoter pledge is zero.
  • ▸FCF yield is positive at 1.5%.
  • ▸11 years of positive FCF.

Trust risks

  • ▸ROCE trend is -2.9%.
  • ▸1 of the latest 4 quarters had PAT decline worse than 25% YoY.
  • ▸OPM spread across recent quarters is 22.7%.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Important announcements & filings

Latest exchange and company disclosures found within the past two years.

12 shown
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Sep - Newspaper Advertisement for special window for relodgement of transfer requests of physical shares

Source: Bse

Open source ↗
Credit rating

Announcement under Regulation 30 (LODR)-Credit Rating 23 Sep - CRISIL reaffirmed Rallis India ratings for Rs. 440 crore bank loans and Rs. 75 crore commercial paper.

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 17 Sep - Details of the meetings scheduled with the Analyst / Institutional Investors

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 10 Sep - Details of the meeting scheduled with Analyst / Institutional Investors

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 26 Aug - Details of the meeting scheduled with Analyst / Institutional Investors

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 10 Aug - Rallis India schedules one-on-one investor meetings with Tata AMC, ICICI Prudential AMC, Jio BlackRock AMC, and Antique Broking.

Source: Bse

Open source ↗
Investor presentationJul 2026

Jul 2026 · PPT

Source: Bse

Open source ↗
Concall transcriptJul 2026

Jul 2026 · Transcript

Source: Bse

Open source ↗
AnnouncementJul 2026

Jul 2026 · Announcement under Regulation 30 (LODR)-Change in Directorate 1d - Padmini Khare Kaicker and Dr. C.V. Natraj ceased as independent directors on July 22, 2026.

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Jul - Newspaper Advertisement for special window for relodgement of transfer requests of physical shares

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s 27 Jul - Rallis India appoints S R B C & CO LLP as statutory auditors from 79th AGM to 84th AGM, subject to approval.

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 12 Jun - Newspaper Advertisement - Public Notice regarding Loss of share certificates

Source: Bse

Open source ↗
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.